Article
Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report.
BMC nephrology - 18 Jul 2017
Alge Joseph L, Wenderfer Scott E, Hicks John, Bekheirnia Mir Reza, Schady Deborah A, Kain Jamey S, Braun Michael C
Abstract excerpt
BACKGROUND: Hemolytic uremic syndrome (HUS) can occur as a primary process due to mutations in complement genes or secondary to another underlying disease. HUS sometimes occurs in the setting of glomerular diseases, and it has been described in association with Denys-Drash syndrome (DDS), which is characterized by the triad of abnormal genitourinary development; a pathognomonic glomerulopathy, diffuse mesangial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.